Previous 10 | Next 10 |
PressReach.com news releases related Pressreach.com news releases and Pressreach.com press releases from 10/11/22 09:33:35 on US and Canada Markets.
Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial plan for its lead psychedelic drug for the treatment of major depressive disorder after r...
Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial plan for its lead psychedelic drug for the treatment of major depressive disorder after r...
Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial plan for its lead psychedelic drug for the treatment of major depressive disorder after r...
Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial plan for its lead psychedelic drug for the treatment of major depressive disorder after r...
Tesla Inc., the uncontested EV heavyweight, has taken its fair share of blows. A string of unfavorable articles has sent the stock ( NASDAQ:TSLA ) to its lowest level since the three-for-one split, which is down more than 30% year to date. The increased trading activity during...
Tesla Inc., the uncontested EV heavyweight, has taken its fair share of blows. A string of unfavorable articles has sent the stock ( NASDAQ:TSLA ) to its lowest level since the three-for-one split, which is down more than 30% year to date. The increased trading activity during...
Tesla Inc., the uncontested EV heavyweight, has taken its fair share of blows. A string of unfavorable articles has sent the stock ( NASDAQ:TSLA ) to its lowest level since the three-for-one split, which is down more than 30% year to date. The increased trading activity during...
DraftKings Stock ( NASDAQ:DKNG ) The possibility of a sports betting relationship between DraftKings ( NASDAQ:DKNG ) and Disney remained a topic of discussion among industry analysts. As a result, DraftKings stock was trading in red today. BTIG analyst Clar...
Nvidia ( NASDAQ:NVDA ) After another analyst issued a cautionary note to investors on Monday, Nvidia stock ( NASDAQ:NVDA ) dropped 4.5% at 1:15 p.m. ET. For his part, Cowen analyst Matthew Ramsay maintained his outperform rating and $180 price target on the...
Twitter Stock ( NYSE:TWTR ) Twitter stock is up 3% on Monday, marking its most significant gain since last Tuesday when billionaire Elon Musk said he wanted to (conditionally) go through with his proposal to acquire Twitter ( NYSE:TWTR ) and take it pri...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
9.53%Change Percent:
Direxion Daily S&P Biotech Bear 3X Shares Company Name:
LABD Stock Symbol:
NYSE Market: